Making the Best Use of Available Weapons for the Inevitable Rivalry-Resistance to EGFR-TKIs

The emergence of epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) revolutionized the treatment of advanced-stage non-small cell lung cancer (NSCLC). Detected in more than 50% of late-stage lung adenocarcinoma in Asian patients, the EGFR mutation was regarded as a golden mutati...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Dongyu, Wang, Jingnan, Liu, Chengming, Luo, Yuejun, Xu, Haiyan, Wang, Yan, Sun, Nan, He, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136294/
https://www.ncbi.nlm.nih.gov/pubmed/37189759
http://dx.doi.org/10.3390/biomedicines11041141

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136294/
https://www.ncbi.nlm.nih.gov/pubmed/37189759
http://dx.doi.org/10.3390/biomedicines11041141

Ejemplares similares